by Scott Larrivee | Apr 30, 2025 | Podcast
In this episode, host Scott Larrivee speaks with Dr. Luke Nordquist, a medical oncologist and Founder/CEO of XCancer, a globally recognized clinical research center. Dr. Nordquist shares the origin story of XCancer—born out of a desire to bring cutting-edge prostate...
by Scott Larrivee | Apr 30, 2025 | News
WEST VALLEY CITY, Utah – April 30, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the appointment of Rachel Culbertson as Vice President of Supply Chain. Culbertson’s leadership will be instrumental as Nusano scales to...
by Scott Larrivee | Apr 16, 2025 | Podcast
On this episode, hosts Scott Larrivee and Sarah Scouten are joined by Matt Furlow, Associate Principal & Head of the Radiopharmaceutical Center of Excellence at ZS, about the evolving role of radiopharmaceuticals in oncology. With a PhD in bioengineering...
by Scott Larrivee | Mar 14, 2025 | Utah
March 14, 2025 – Nusano’s radioisotope production platform is profiled in a Salt Lake City Business Journal article: Chris Lowe, company CEO, said the origin of Nusano was “to address the underlying problems that have plagued national research labs and...
by Scott Larrivee | Mar 6, 2025 | Podcast
In this episode of Talk Radioisotopes, hosts Scott and Sarah welcome Bruno Paquin, CEO of AtomVie Global Radiopharma.Bruno delves into the complexities and advancements of the radiopharmaceutical industry. The discussion highlights AtomVie’s role as a leading contract...
